FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3129021569> ?p ?o ?g. }

• W3129021569 abstract "Abstract Glioblastoma (GBM), the most aggressive primary brain tumor, has a dismal prognosis. Despite our growing knowledge of genomic and epigenomic alterations in GBM, standard therapies and outcomes have not changed significantly in the past two decades. There is therefore an urgent unmet need to develop novel therapies for GBM. The inter- and intratumoral heterogeneity of GBM, inadequate drug concentrations in the tumor owing to the blood–brain barrier, redundant signaling pathways contributing to resistance to conventional therapies, and an immunosuppressive tumor microenvironment, have all hindered the development of novel therapies for GBM. Given the high frequency of DNA damage pathway alterations in GBM, researchers have focused their efforts on pharmacologically targeting key enzymes, including poly(ADP-ribose) polymerase (PARP), DNA-dependent protein kinase, ataxia telangiectasia-mutated, and ataxia telangiectasia and Rad3-related. The mainstays of GBM treatment, ionizing radiation and alkylating chemotherapy, generate DNA damage that is repaired through the upregulation and activation of DNA damage response (DDR) enzymes. Therefore, the use of PARP and other DDR inhibitors to render GBM cells more vulnerable to conventional treatments is an area of intense investigation. In this review, we highlight the growing body of data behind DDR inhibitors in GBM, with a focus on putative predictive biomarkers of response. We also discuss the challenges involved in the successful development of DDR inhibitors for GBM, including the intracranial location and predicted overlapping toxicities of DDR agents with current standards of care, and propose promising strategies to overcome these hurdles." @default.
• W3129021569 created "2021-02-15" @default.
• W3129021569 creator A5016068761 @default.
• W3129021569 creator A5019982782 @default.
• W3129021569 creator A5025131780 @default.
• W3129021569 creator A5033263947 @default.
• W3129021569 creator A5035482209 @default.
• W3129021569 creator A5036347055 @default.
• W3129021569 creator A5052632461 @default.
• W3129021569 creator A5068368047 @default.
• W3129021569 creator A5071489703 @default.
• W3129021569 date "2021-01-01" @default.
• W3129021569 modified "2023-10-15" @default.
• W3129021569 title "The promise of DNA damage response inhibitors for the treatment of glioblastoma" @default.
• W3129021569 cites W1863440278 @default.
• W3129021569 cites W1882891727 @default.
• W3129021569 cites W1975155994 @default.
• W3129021569 cites W1980842169 @default.
• W3129021569 cites W1986830781 @default.
• W3129021569 cites W1998023952 @default.
• W3129021569 cites W2019219567 @default.
• W3129021569 cites W2025183726 @default.
• W3129021569 cites W2029304297 @default.
• W3129021569 cites W2038257557 @default.
• W3129021569 cites W2039442869 @default.
• W3129021569 cites W2039913198 @default.
• W3129021569 cites W2043895957 @default.
• W3129021569 cites W2043990544 @default.
• W3129021569 cites W2046589688 @default.
• W3129021569 cites W2048573295 @default.
• W3129021569 cites W2050565506 @default.
• W3129021569 cites W2074429674 @default.
• W3129021569 cites W2080503650 @default.
• W3129021569 cites W2094646262 @default.
• W3129021569 cites W2096024448 @default.
• W3129021569 cites W2096287682 @default.
• W3129021569 cites W2100285961 @default.
• W3129021569 cites W2102614717 @default.
• W3129021569 cites W2102794619 @default.
• W3129021569 cites W2105100844 @default.
• W3129021569 cites W2109816625 @default.
• W3129021569 cites W2111736935 @default.
• W3129021569 cites W2117389132 @default.
• W3129021569 cites W2118915687 @default.
• W3129021569 cites W2121585125 @default.
• W3129021569 cites W2131077173 @default.
• W3129021569 cites W2131670056 @default.
• W3129021569 cites W2134457209 @default.
• W3129021569 cites W2137771267 @default.
• W3129021569 cites W2145200068 @default.
• W3129021569 cites W2158402289 @default.
• W3129021569 cites W2159311956 @default.
• W3129021569 cites W2161289668 @default.
• W3129021569 cites W2163529853 @default.
• W3129021569 cites W2165400661 @default.
• W3129021569 cites W2173218669 @default.
• W3129021569 cites W2303158491 @default.
• W3129021569 cites W2307481467 @default.
• W3129021569 cites W2346904924 @default.
• W3129021569 cites W2411596856 @default.
• W3129021569 cites W2478155564 @default.
• W3129021569 cites W2509121458 @default.
• W3129021569 cites W2523123787 @default.
• W3129021569 cites W2524525752 @default.
• W3129021569 cites W2526716574 @default.
• W3129021569 cites W2527992063 @default.
• W3129021569 cites W2529308344 @default.
• W3129021569 cites W2552085642 @default.
• W3129021569 cites W2570696586 @default.
• W3129021569 cites W2585230893 @default.
• W3129021569 cites W2587333476 @default.
• W3129021569 cites W2588147230 @default.
• W3129021569 cites W2595193895 @default.
• W3129021569 cites W2626614537 @default.
• W3129021569 cites W2727619305 @default.
• W3129021569 cites W2733051925 @default.
• W3129021569 cites W2736286118 @default.
• W3129021569 cites W2759177017 @default.
• W3129021569 cites W2769630938 @default.
• W3129021569 cites W2770779508 @default.
• W3129021569 cites W2783692774 @default.
• W3129021569 cites W2787120596 @default.
• W3129021569 cites W2787702713 @default.
• W3129021569 cites W2791913001 @default.
• W3129021569 cites W2799695804 @default.
• W3129021569 cites W2802314931 @default.
• W3129021569 cites W2804434998 @default.
• W3129021569 cites W2804524291 @default.
• W3129021569 cites W2809134358 @default.
• W3129021569 cites W2891790331 @default.
• W3129021569 cites W2898476557 @default.
• W3129021569 cites W2899687438 @default.
• W3129021569 cites W2903876972 @default.
• W3129021569 cites W2904519862 @default.
• W3129021569 cites W2911653212 @default.
• W3129021569 cites W2915645504 @default.
• W3129021569 cites W2918252715 @default.
• W3129021569 cites W2946448900 @default.
• W3129021569 cites W2954958518 @default.
• W3129021569 cites W2955082801 @default.

• next